Stay updated on Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.

Latest updates to the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded the latest site revision banner: Revision: v3.4.2, and removed older notices including the funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedShow glossary is now available. The page includes a new 'Last Update Submitted that Met QC Criteria' label, updated capitalization for 'No FEAR Act Data', and the revision tag changed from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page version was updated from v3.3.3 to v3.3.4; there are no changes to the study details, locations, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded the Locations section and updated to Revision v3.3.3; removed HHS Vulnerability Disclosure, Migration Data Locations, and Revision v3.3.2.SummaryDifference0.2%

Stay in the know with updates to Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.